Portfolio

New Portfolio since 2020

Avilar Therapeutics, Inc. (MA, USA)

Extracellular protein degradation

Casma Therapeutics, Inc. (MA, USA)

Targeted degradation by autophagy

Carbon Biosciences logo

Carbon Biosciences, Inc. (MA, USA)

Non-AAV, Parvovirus-based vector platform

Catamaran Bio, Inc. (MA, USA)

Synthetic innate immunology

Cellular Intelligence, Inc. (MA, USA)

AI driven cell therapy

DEM BioPharma, Inc. (MA, USA)

Bifunctional ADC

Mogrify Limited (Cambridge, UK)

Ex vivo/In vivo cell conversion

NeoPhore Limited (Cambridge, UK)

DNA mismatch repair system

Orna Therapeutics Holdings, LLC (MA, USA)

Circular RNA-based cell engineering

 

M&A

Pallando Therapeutics, Inc. (CA, USA)

Tissue-sparing protein degraders

PhoreMost Limited (Cambridge, UK)

PROTAC& Peptide-based phenotypic screening

ResNovas Therapeutics, Inc. (CA, USA)

Novel induced proximity degradation modalities

Restore Vision, Inc. (Tokyo, Japan)

AAV-based Optogenetics

Sidewinder Therapeutics, Inc. (CA, USA)

Bispecific ADCs

Shinobi Therapeutics, Inc. (CA, USA)

Hypoimmune iPSC derived T cell therapy

Solu Therapeutics, Inc. (MA, USA)

Antibody-intractable cell surface targets

Stealth mode Company (Invested in 2022 Feb) (NA)

RNA biology

Syntax Bio, Inc. (IL, USA)

Cell differentiation discovery platform

Toregem BioPharma Co., Ltd (Kyoto, Japan)

Antibody-based tooth regeneration

Turn Biotechnologies, Inc. (CA, USA)

mRNA/LNP based in vivo cell rejuvenation

Weaver Biosciences, Inc. (MA, USA)

Targeted gene modulation with small molecule pharmacology


Former Investments

Redona Therapeutics, Inc (MA, USA)

Bicycle Therapeutics Ltd (Cambridge, UK)

IPO

Cleave Biosciences, Inc (CA, USA)

CODA Biotherapeutics, Inc (CA, USA)

Crescendo Biologics Ltd (Cambridge, UK)

eFFECTOR Therapeutics, Inc (CA, USA)

SPAC merger

Heartseed Inc (Tokyo, Japan)

IPO

Oncorus, Inc 
(MA, USA)

IPO

Tizona Therapeutics, Inc (CA, USA)

Trieza Therapeutics, Inc (MA, USA)

Trishula Terapeutics, Inc (CA, USA)

TScan Therapeutics, Inc (MA, USA)

IPO

Viamet Pharmaceuticals, Inc (NC, USA)

F2G Ltd (Manchester,UK)

PanOptica, Inc (NJ, USA)

Contact

Astellas Venture Management LLC